Search

01/05/2025 Metabolic dysfunction-and alcohol-associated steatotic liver disease is associated with higher risk of advanced fibrosis and mortality than metabolic dysfunction-associated steatotic liver disease: data from a large global biopsy-proven cohort
Younossi, Z, de Avila, L, Petta, S, Nakajima, A, Crespo, J, Kim, SU, Castera, L, Zheng, MH, Tsochatzis, E, Trivikrama, SK, Shalimar, S, Alswat, KA, Yilmaz, Y, Yu, ML, Francque, S, Chan, WK, Fernández, MIC, Treeprasertsuk, S, Duseja, AK, Gadano, A, Oliveira, CP, Arab, JP, Papatheodoridis, G, Diaz, LA, Sebastiani, G, D'Ambrosio, R, Valsan, A, Khalid, A, Holleboom, AG, El-Kassas, M, Pugliese, N, Singal, AK, Pearlman, B, Choudhary, NS, Cordie, A, Gunn, N, Caussy, C, Mauricio, D, Kawaguchi, T, Russo, FP, Venu, A, Hagström, H, Alkhouri, N, Ananchuensook, P, Mohan, L, Fan, JA, Roberts, S, Wong, VWS, Dunn, W, Ekstedt, M, Goh, GBB, Pessoa, M, Lampertico, P, Pennisi, G, Shang, Y, Liu, WY, Lee, HW, Kobayashi, T, Kakizaki, S, Iruzubieta, P, Nadeem, R, Cinque, F, Neonaki, A, Zoncapè, M, Yang, RX, Song, SJ, Dunn, N, Gadi, Z, Yeh, ML, Teh, KKJ, Mahadeva, S, Fabian, LG, Almohsen, A, Leite, N, Vessby, J, Xie, CC, Friend, E, Poca, M, Segrestin, B, Arrese, M, Lam, B, Racila, A, Alqahtani, S, Stepanova, M. Metabolic dysfunction-and alcohol-associated steatotic liver disease is associated with higher risk of advanced fibrosis and mortality than metabolic dysfunction-associated steatotic liver disease: data from a large global biopsy-proven cohort. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025 Phase angle as a predictive factor for mortality in hospitalized patients with cirrhosis
Javier, FO, Sánchez, J, Roman, E, Miquel, M, Kaur, N, Ferrusquía-Acosta, J, Poca, M, Solé, C, Cuyàs, B, Casas, M, Alvarado-Tapias, E, Monllor-Nunell, T, Sheila, A, Andreu, F, Brujats, A, Vergara, M, Escorsell, A, Soriano, G. Phase angle as a predictive factor for mortality in hospitalized patients with cirrhosis. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025 Dynamics and prognostic implications of splanchnic volumetry in patients withportosinusoidal vascular liver disorder
Ferrusqu a-Acosta, J, Gil-Bello, D, Lampichler, K, Vidal, M, Fuertes, D, Simonis, L, Wu, CJ, Shen, Y, Luo, XF, G mez, FT, Parada-Bl zquez, MJ, Gir ldez-Gallego, A, S nchez-Lorenzo, A, Selva-Tal n, D, Alvarado-Tapias, E, Saltini, D, Squecco, D, Schepis, F, Giudicelli, H, Wagner, M, Thabut, D, Garc a-Calonge, M, Uceda-Andr s, E, Alvarez-Navascu s, C, Koc, O, Miclea, R, Maderuelo, E, Herrera, EL, Casas, M, Miquel, M, Vergara, M, Balcar, L, S nchez, J, Sol , C, Scheiner, B. Dynamics and prognostic implications of splanchnic volumetry in patients withportosinusoidal vascular liver disorder. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025 Anemia following portal hypertension-related bleeding in liver cirrhosis: incidence and impact on prognosis
Ojeda, A, Magaz, M, Agulleiro, I, Pascual, I, Jimenez-Esquivel, N, Pèlach, A, Cháfer, IT, García-García, S, Maderuelo, E, Puente, A, Cobreros, M, Gonzalez, JV, Amador, A, Alvarado-Tapias, E, Gonzílez-Alayón, C, Téllez, L, Manzano, F, Bernal, V, Lomas, R, Ferrusquía-Acosta, J, Perez, V, Shalaby, S, Baiges, A, Turon, F, Hernández-Gea, V, Romero-Gutiérrez, M, Vives-Moreno, J, Albillos, A, Morant, A, Alonso, JC, Simón-Talero, M, Fortea, J, Herrera, EL, Aguilera, V, Masnou, H, Giráldez-Gallego, A, García-Pagán, JC. Anemia following portal hypertension-related bleeding in liver cirrhosis: incidence and impact on prognosis. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
01/05/2025 A global analysis of patients with metabolic dysfunction associated steatotic liver disease with liver biopsy, non-invasive tests and mortality
Younossi, Z, de Avila, L, Petta, S, Hagström, H, Kim, SU, Nakajima, A, Crespo, J, Castera, L, Alkhouri, N, Zheng, MH, Treeprasertsuk, S, Ananchuensook, P, Shalimar, S, Tsochatzis, E, Trivikrama, SK, Mohan, L, Fan, JA, Roberts, S, Alswat, KA, Wong, VWS, Yilmaz, Y, Dunn, W, Francque, S, Cordie, A, Yu, ML, Ekstedt, M, Goh, GBB, Oliveira, CP, Pessoa, M, Chan, WK, Fernández, MIC, Duseja, AK, Arab, JP, Papatheodoridis, G, Sebastiani, G, Villela-Nogueira, C, D'Ambrosio, R, Lampertico, P, Khalid, A, Holleboom, AG, Valsan, A, El-Kassas, M, Pennisi, G, Shang, Y, Liu, WY, Lee, HW, Kobayashi, T, Kakizaki, S, Caussy, C, Pearlman, B, Iruzubieta, P, Nadeem, R, Cinque, F, Neonaki, A, Zoncapè, M, Yang, RX, Song, SJ, Dunn, N, Gadi, Z, Yeh, ML, Teh, KKJ, Mahadeva, S, Fabian, LG, Almohsen, A, Leite, N, Pugliese, N, Vessby, J, Xie, CC, Choudhary, NS, Friend, E, Poca, M, Kawaguchi, T, Russo, FP, Gadano, A, Singal, AK, Diaz, LA, Ségrestin, B, Gunn, N, Mauricio, D, Arrese, M, Lam, B, Racila, A, Alqahtani, S, Stepanova, M. A global analysis of patients with metabolic dysfunction associated steatotic liver disease with liver biopsy, non-invasive tests and mortality. JOURNAL OF HEPATOLOGY. 2025; 82DOI:. PMID:. IF:33.000(Q1/1D).
19/04/2025 Pentoxifylline use in alcohol-associated hepatitis with acute kidney injury does not improve survival: a global study
Idalsoaga, F, Diaz, LA, Dunn, W, Mehta, H, Caldentey, V, Arnold, J, Ayares, G, Sarin, SK, Maiwall, R, Zhang, W, Qian, S, Simonetto, D, Singal, AK, Elfeki, MA, Khan, MQ, Mortuza, R, Malhi, G, Islam, AH, Guizzetti, L, Ramirez-Cadiz, C, Cabezas, J, Echavarria, V, Poca, M, Cuyas, B, Soriano, G, Cots, MV, Higuera-De La Tijera, MF, Abraldes, JG, Al-Karaghouli, M, Skladany, L, Havaj, DJ, Rincón, D, Shah, V, Arrese, M, Kamath, PS, Bataller, R, Arab, JP. Pentoxifylline use in alcohol-associated hepatitis with acute kidney injury does not improve survival: a global study. Egastroenterology. 2025; 3(2)DOI:10.1136/egastro-2024-100179. PMID:40276593. IF:(Q/D).
01/04/2025 Preventing the progression of cirrhosis to decompensation and death
Villanueva, C, Tripathi, D, Bosch, J. Preventing the progression of cirrhosis to decompensation and death. Nature Reviews Gastroenterology & Hepatology. 2025; 22(4)DOI:10.1038/s41575-024-01031-x. PMID:39870944. IF:51.000(Q1/1D).
01/04/2025 Recompensation in Cirrhosis: Biomarkers and Strategies
Ramírez-Quesada, W, Alvarado-Tapias, E, Shalaby, S, Hernández-Gea, V. Recompensation in Cirrhosis: Biomarkers and Strategies. SEMINARS IN LIVER DISEASE. 2025; 45(01)DOI:10.1055/a-2542-9930. PMID:40179966. IF:3.700(Q2/3D).
01/04/2025 Moderate alcohol-associated hepatitis: A real-world multicenter study
Idalsoaga, F, Díaz, LA, Dunn, W, Mehta, H, Muñoz, K, Caldentey, V, Arnold, J, Ayares, G, Mortuza, R, Sarin, SK, Maiwall, R, Zhang, W, Qian, S, Simonetto, D, Singal, AK, Elfeki, MA, Ramirez-Cadiz, C, Malhi, G, Ahmed, A, Homsi, H, Abid, Z, Cabezas, J, Echavarría, V, Poca, M, Soriano, G, Cuyas, B, Cots, MV, Higuera-De La Tijera, MF, Ayala-Valverde, M, Perez, D, Gomez, J, Abraldes, JG, Al-Karaghouli, M, Jalal, PK, Ibrahim, MA, García-Tsao, G, Goyes, D, Skladany, L, Havaj, DJ, Sulejova, K, Selcanova, SA, Rincón, D, Chacko, KR, Restrepo, JC, Yaquich, P, Toro, LG, Shah, V, Arrese, M, Kamath, PS, Bataller, R, Arab, JP. Moderate alcohol-associated hepatitis: A real-world multicenter study. Hepatology Communications. 2025; 9(4)DOI:10.1097/HC9.0000000000000673. PMID:40131003. IF:4.600(Q1/2D).
11/03/2025 Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial
Pose, E, Jiménez, C, Zaccherini, G, Campion, D, Piano, S, Uschner, FE, de Wit, K, Roux, O, Gananandan, K, Laleman, W, Solé, C, Alonso, S, Cuyàs, B, Ariza, X, Juanola, A, Ma, AT, Napoleone, L, Gratacós-Ginès, J, Tonon, M, Pompili, E, Sánchez-Delgado, J, Allegretti, AS, Morales-Ruiz, M, Carol, M, Pérez-Guasch, M, Fabrellas, N, Pich, J, Martell, C, Joyera, M, Domenech, G, Ríos, J, Torres, F, Serra-Burriel, M, Hernáez, R, Solà, E, Graupera, I, Watson, H, Soriano, G, Bañares, R, Mookerjee, RP, Francoz, C, Beuers, U, Trebicka, J, Angeli, P, Alessandria, C, Caraceni, P, Vargas, VM, Abraldes, JG, Kamath, PS, Ginès, P, LIVERHOPE Consortium. Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2025; 333(10)DOI:10.1001/jama.2024.27441. PMID:39908052. IF:55.000(Q1/1D).
01/03/2025 Basal PD-L1 expression on leukocyte subpopulations in patients with extensive-stage small cell lung cancer treated with first-line atezolizumab plus platinum and etoposide
Beltrans, JS, Guinart-Cuadra, A, Piedras, A, Recios, SM, Mulet, M, Atenza, CZ, Alejandre, J, Joaquíns, AB, Sullivans, IG, Lópezs, JS, Vidal, S, Majems, M. Basal PD-L1 expression on leukocyte subpopulations in patients with extensive-stage small cell lung cancer treated with first-line atezolizumab plus platinum and etoposide. Journal of Thoracic Oncology. 2025; 20(3)DOI:. PMID:. IF:20.800(Q1/1D).
01/03/2025 Faecal calprotectin-based strategy for long-term monitoring of patients with Crohn's disease without or with mild endoscopic postoperative recurrence
Mañosa, M, Oller, B, Garcia-Planella, E, Guardiola, J, Cañete, F, González-Muñoza, C, Camps, B, Calafat, M, Doménech, E. Faecal calprotectin-based strategy for long-term monitoring of patients with Crohn's disease without or with mild endoscopic postoperative recurrence. DIGESTIVE AND LIVER DISEASE. 2025; 57(3)DOI:10.1016/j.dld.2024.11.028. PMID:39730282. IF:3.800(Q2/3D).
01/03/2025 Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: A post hoc analysis of the PREDESCI trial
Dajti, E, Villanueva, C, Berzigotti, A, Brujats, A, Albillos, A, Genescà, J, García-Pagán, JC, Colecchia, A, Bosch, J. Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: A post hoc analysis of the PREDESCI trial. JOURNAL OF HEPATOLOGY. 2025; 82(3)DOI:10.1016/j.jhep.2024.09.014. PMID:39303875. IF:33.000(Q1/1D).
01/02/2025 Progressive systemic inflammation precedes decompensation in compensated cirrhosis
Sánchez-Aldehuelo, R, Villanueva, C, Genescà, J, García-Pagán, JC, Castillo, E, Calleja, JL, Aracil, C, Bañares, R, Téllez, L, Paule, L, Morillas, RM, Poca, M, Peñas, B, Augustin, S, Abraldes, JG, Alvarado-Tapias, E, Bosch, J, Albillos, A. Progressive systemic inflammation precedes decompensation in compensated cirrhosis. Jhep Reports. 2025; 7(2)DOI:10.1016/j.jhepr.2024.101231. PMID:39850960. IF:7.500(Q1/2D).
01/02/2025 Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU
Mesonero, F, Zabana, Y, Fernández-Clotet, A, Solá, A, Caballol, B, Leo-Carnerero, E, García, MJ, Bertoletti, F, Bastida, G, Suris, G, Casis, B, Ferreiro-Iglesias, R, Calafat, M, Jiménez, I, Miranda-Bautista, J, Lamuela, LJ, Fajardo, I, Torrealba, L, Nájera, R, Sáiz-Chumillas, RM, González-Partida, I, Vicuña, M, García-Morales, N, Gutiérrez, A, López-García, A, Benitez, JM, de Célix, CR, Tejido, C, Brunet, E, Hernandez-Camba, A, Suárez, C, Rodríguez-Lago, I, Piqueras, M, Castaño, A, Ramos, L, Sobrino, A, Rodríguez-Grau, MC, Elosua, A, Montoro, M, Baltar, R, Huguet, JM, Hermida, B, Caballero-Mateos, A, Sánchez-Guillén, L, Bouhmidi, A, Pajares, R, Baston-Rey, I, López-Sanromán, A, Albillos, A, Barreiro-de Acosta, M. Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU. DIGESTIVE AND LIVER DISEASE. 2025; 57(2)DOI:10.1016/j.dld.2024.09.023. PMID:39455313. IF:3.800(Q2/3D).
01/02/2025 Alcohol-associated liver disease: Natural history, management and novel targeted therapies
Alvarado-Tapias, E, Pose, E, Gratacós-Ginès, J, Clemente-Sánchez, A, López-Pelayo, H, Bataller, R. Alcohol-associated liver disease: Natural history, management and novel targeted therapies. Clinical and Molecular Hepatology. 2025; 31DOI:10.3350/cmh.2024.0709. PMID:39481875. IF:16.900(Q1/1D).
01/02/2025 Asymptomatic Inflammatory Bowel Disease Diagnosed During Colorectal Cancer Population Screening in Catalonia: Characteristics and Natural History
Brunet-Mas, E, Selva, A, Bas-Cutrina, F, Brujats, A, Caballol, B, Font, R, Gómez, B, Gonzalez-Muñosa, C, Busquets, D, Monfort, D, Vera, DP, Maristany, E, Cirera, G, Torres, G, Castro-Poceiro, J, Lopez, J, Gonzalez-Gonzalez, L, Márquez-Mosquera, L, Gallach, M, Esteve, M, Tremosa, G, Torra, S, Robles-Alonso, V, Garcia-Iglesias, P, Rodríguez-Lago, I, Calvet, X. Asymptomatic Inflammatory Bowel Disease Diagnosed During Colorectal Cancer Population Screening in Catalonia: Characteristics and Natural History. Clinical and Translational Gastroenterology. 2025; 16(2)DOI:10.14309/ctg.0000000000000740. PMID:39729123. IF:3.000(Q2/4D).
22/01/2025 Inter-rater disagreements in applying the Montreal classification for Crohn's disease: The Five-Nations Survey Study
Ukashi, O, Amiot, A, Laharie, D, Menchén, L, Gutierrez, A, Fernandes, S, Pessarelli, T, Correia, F, Gonzalez-Muñoza, C, López-Cardona, J, Acosta, MBD, Yanai, H, Armuzzi, A, Magro, F, Kopylov, U. Inter-rater disagreements in applying the Montreal classification for Crohn's disease: The Five-Nations Survey Study. Journal of Crohns & Colitis. 2025; 19DOI:10.1093/ecco-jcc/jjae190.0425. PMID:. IF:8.700(Q1/1D).
22/01/2025 Postoperative recurrence after a definitive ostomy in Crohn's disease. A nationwide retrospective series from the Eneida registry
Sard, MC, Mañosa, M, Fernández-Clotet, A, Pasanau, L, Matallana,, Iglesias, E, Hernández-Camba, A, Ucha, P, Nos, P, Barrio, J, Gutiérrez, A, Merino,, Barreiro-de Acosta, M, Cudero, L, Casanova, MJ, González-Muñoza, C, Bujanda, L, Varela, P, Bermejo, F, Torres, N, Mesonero, F, Calvet, X, Rivas, C, Perez, C, Alonso-Abreu,, Rodríguez-Lago,, Vega, P, Zabana, Y, Mora, M, Busquets, D, Rodríguez-Gutiérrez, C, Torres, G, Valldosera, G, Ponferrada, A, Ceballos, D, Pascual, CM, Jiménez, N, Sampedro, M, Irabien, M, Domènech, E, ENEIDA registry, GETECCU. Postoperative recurrence after a definitive ostomy in Crohn's disease. A nationwide retrospective series from the Eneida registry. Journal of Crohns & Colitis. 2025; 19DOI:10.1093/ecco-jcc/jjae190.0400. PMID:. IF:8.700(Q1/1D).
01/01/2025 Ileal Predominance in Crohn's Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence
Giordano, A, Pérez-Martínez, I, Gisbert, JP, Ricart, E, Martín-Arranz, MD, Mesonero, F, Parga, MLD, Rivero, M, Iglesias, E, Fernández-Prada, S, Calafat, M, Villarino, MTA, Turrión, MAD, Hernández-Camba, A, Lidón, RV, Carpio, D, Brunet, E, Moranta, FR, García, LA, Cuquerella, JT, Bermejo, F, Madero, L, Esteve, M, González-Muñoza, C, Martínez-Montiel, P, Huguet, JM, Calle, JLP, Rodríguez-Lago, I, Ausín, MS, Poyatos, RHL, García-Bosch, O, Marín, GS, Taxonera, C, Ponferrada-Diaz, A, Barreiro-de Acosta, M, Bujanda, L, Serra, RB, Ramos, L, Vera, I, Abizanda, ES, Piqueras, M, Gómez, CS, García-Sepulcre, MF, Arregui, MV, Murillo, NR, Llaó, J, Lucendo, AJ, Marín-Jiménez, I, Camps-Aler, B, Villafranca, CM, Ceballos, D, Ver, Y, Fernández-Salazar, LI, Alcaín, G, Valldosera, G, Andrés, PR, Martínez-Flores, C, Coronel, AF, Ginard, D, García, L, Gomez, IB, Argueelles-Arias, F, Miyashiro, EI, de la Piscina, PR, Villalba, LH, Notari, PA, Martínez-Pérez, TD, Fernández, H, Gilabert, P, Rosas, CM, Nos, P, Gil, JL, López, VMN, Muñoz, F, Palomares, MTDL, Lucio, AS, Merino, O, de Prado, IN, Leal, C, de Carpi, JM, Sánchez, LB, Arce, NM, Frago, S, Mateu, BB, Domènech, E, Planella, EG. Ileal Predominance in Crohn's Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2025; 120(1)DOI:10.14309/ajg.0000000000003207. PMID:39745305. IF:7.600(Q1/1D).
01/01/2025 Vitamin D Supplementation Is Associated with Inflammation Amelioration and Cognitive Improvement in Decompensated Patients with Cirrhosis
Diaz-Ruiz, R, Poca, M, Roman, E, Panadero-Gomez, R, Cuyàs, B, Bañares, I, Morales, A, Puerto, M, Lopez-Esteban, R, Blazquez, E, Fernández-Castillo, M, Correa-Rocha, R, Rapado-Castro, M, Breton, I, Bañares, R, Soriano, G, Garcia-Martinez, R. Vitamin D Supplementation Is Associated with Inflammation Amelioration and Cognitive Improvement in Decompensated Patients with Cirrhosis. Nutrients. 2025; 17(2)DOI:10.3390/nu17020226. PMID:39861356. IF:5.000(Q1/2D).
01/12/2024 Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study
Perez-Campuzano, V, Rautou, PE, Marjot, T, Praktiknjo, M, Alvarado-Tapias, E, Turco, L, Ibáñez-Samaniego, L, González-Alayón, C, Puente, A, Llop, E, Simón-Talero, M, álvarez-Navascués, C, Reiberger, T, Verhelst, X, Tellez, L, Bergmann, JB, Orts, L, Grassi, G, Baiges, A, Audrey, P, Trebicka, J, Villanueva, C, Morelli, MC, Murray, S, Meacham, G, Luetgehetmann, M, Wiesch, JSZ, García-Pagán, JC, Barnes, E, Plessier, A, Hernández-Gea, V. Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study. Jhep Reports. 2024; 6(12)DOI:10.1016/j.jhepr.2024.101191. PMID:39583091. IF:7.500(Q1/2D).
01/11/2024 Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA
Gargallo-Puyuelo, CJ, Ricart, E, Iglesias, E, de Francisco, R, Gisbert, JP, Taxonera, C, Mañosa, M, Peris, MA, Navarrete-Muñoz, EM, Sanahuja, A, Guardiola, J, Mesonero, F, Tirado, MR, Barrio, J, Mendoza, IV, Parga, LD, García-Planella, E, Calvet, X, Arranz, MDM, García, S, Sicilia, B, Carpio, D, Domenech, E, Gomollón, F. Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA. Clinical Gastroenterology and Hepatology. 2024; 22(11)DOI:10.1016/j.cgh.2024.05.013. PMID:38782172. IF:12.000(Q1/1D).
01/10/2024 PTIPS IS ASSOCIATED WITH BETTER OUTCOMES IN PATIENTS WITH ACUTE VARICEAL BLEEDING AND SEVERE ALCOHOLIC HEPATITIS
Hernandez-Gea, RMV, Bouzbib, C, Procopet, B, Aznar, AB, Turon, F, Larrue, H, Sanchez, CV, Albillos, A, Gluud, L, Guardascione, M, Praktiknjo, P, Cots, M, Ridaura, HM, Laleman, W, Bureau, C, Mandorfer, M, Tapias, E, Gallego, AG, Zipprich, A, Hartl, L, Hidalgo, NC, Deckmyn, O, Garcia-Pagan, JC, Thabut, D. PTIPS IS ASSOCIATED WITH BETTER OUTCOMES IN PATIENTS WITH ACUTE VARICEAL BLEEDING AND SEVERE ALCOHOLIC HEPATITIS. HEPATOLOGY. 2024; 80DOI:. PMID:. IF:15.800(Q1/1D).
01/09/2024 Recurrent splanchnic and extrasplanchnic thrombotic events in patients with non-cirrhotic portal vein thrombosis associated with local factors
Ollivier-Hourmand, I, Lebedel, L, Alabau, BB, Goria, O, Bureau, C, Dumortier, J, Heurgue, A, Silvain, C, De-Ledinghen, V, Rautou, PE, Payance, A, Ballester, TG, Alvarado-Tapias, E, Hernandez-Gea, V, Valla, D, Zekrini, K, Nguyen, TTN, Dao, T, Pagan, JCG, Morello, R, Plessier, A. Recurrent splanchnic and extrasplanchnic thrombotic events in patients with non-cirrhotic portal vein thrombosis associated with local factors. JOURNAL OF HEPATOLOGY. 2024; 81(3)DOI:10.1016/j.jhep.2024.04.016. PMID:38679069. IF:33.000(Q1/1D).
01/06/2024 Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation
Ballester, MP, Laue, T, Meoli, L, Uson, E, Mutschler, F, Grabitz, C, McLin, V, D'Antiga, L, Pujadas, M, Carvalho-Gomes, A, Sahuco, I, Bono, A, D'Amico, F, Viganò, R, Sempere, ED, Tormo, B, Inglese, E, Martinez, D, Riva, A, Sharma, R, Tsou, HLP, Harris, N, Broekhoven, A, Kikkert, M, Morales, S, Myeni, S, Barciela, MR, Palom, A, Zeni, N, Brocca, A, Cussigh, A, Cmet, S, Escudero-García, D, Stocco, M, Natola, L, Ieluzzi, D, Paon, V, Sangiovanni, A, Farina, E, Di Benedetto, C, Sanchez-Torrijos, YM, Valera, AL, Roman, E, Sanchez, E, Sánchez-Aldehuelo, R, López-Cardona, J, Canas-Perez, I, Jackson, C, Jeyanesan, D, Morocho, AE, Di Cola, S, Lapenna, L, Zaccherini, G, Bongiovanni, D, Zanaga, P, Sayaf, K, Hossain, S, Crespo, J, Robles-Díaz, M, Madejón, A, Degroote, H, Fernández, J, Korenjak, M, Verhelst, X, Garcia-Samaniego, FJ, Andrade, RJ, Iruzubieta, P, Wright, G, Caraceni, P, Merli, M, Patel, VC, Gander, A, Albillos, A, Soriano, G, Donato, MF, Sacerdoti, D, Toniutto, P, Buti, M, Duvoux, C, Grossi, PA, Berg, T, Polak, W, Puoti, M, Bosch, A, Belli, LS, Burra, P, Russo, FP, Coenraad, M, Panero, JLC, Perricone, G, Chokshi, S, Berenguer, M, Clària, J, Moreau, R, Arroyo, V, Angeli, P, Sanchez, C, Ampuero, J, Piano, S, Nicastro, E. Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation. JOURNAL OF HEPATOLOGY. 2024; 80DOI:. PMID:. IF:33.000(Q1/1D).
01/06/2024 Chronic pancreatitis for the clinician: complications and special forms of the disease. Interdisciplinary position paper of the Catalan Society of Digestology (SCD) and the Catalan Pancreatic Society (SCPanc)
Molero, X, Ayuso, JR, Balsells, J, Boadas, J, Busquets, J, Casteras, A, Concepcion, M, Cuatrecasas, M, Esparrach, GF, Fort, E, Borobia, FG, Gines, A, Ilzarbe, L, Loras, C, Masachs, M, Merino, X, Olsina, JJ, Puig-Divi, V, Salord, S, Serrano, T, Vaquero, EC. Chronic pancreatitis for the clinician: complications and special forms of the disease. Interdisciplinary position paper of the Catalan Society of Digestology (SCD) and the Catalan Pancreatic Society (SCPanc). Minerva Gastroenterology. 2024; 70(2)DOI:10.23736/S2724-5985.22.03127-8. PMID:35262306. IF:1.500(Q4/8D).
01/06/2024 Incidence of herpes zoster in patients with inflammatory bowel disease
Calm, A, Calafat, M, González-Muñoza, C, Cañete, F, Roig, C, Mañosa, M, García-Planella, E, Domènech, E. Incidence of herpes zoster in patients with inflammatory bowel disease. Gastroenterologia y Hepatologia. 2024; 47(6)DOI:10.1016/j.gastrohep.2024.01.011. PMID:38316174. IF:1.900(Q3/7D).
01/07/2022 Tegumentary leishmaniasis by Leishmania braziliensis complex in Cochabamba, Bolivia including the presence of L. braziliensis outlier Tegumentary leishmaniasis in Cochabamba, Bolivia
Torrico, MC, Fernandez-Arevalo, A, Ballart, C, Solano, M, Rojas, E, Ariza, E, Tebar, S, Lozano, D, Abras, A, Gascon, J, Picado, A, Munoz, C, Torrico, F, Gallego, M. Tegumentary leishmaniasis by Leishmania braziliensis complex in Cochabamba, Bolivia including the presence of L. braziliensis outlier Tegumentary leishmaniasis in Cochabamba, Bolivia. Transboundary and Emerging Diseases. 2022; 69(4)DOI:10.1111/tbed.14228. PMID:34232559. IF:4.300(Q1/1D).
01/12/2021 A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?
Gomez-Zorrilla, S, Becerra-Aparicio, F, Montesinos, IL, de Gopegui, ER, Grau, I, Pintado, V, Padilla, B, Benito, N, Boix-Palop, L, Farinas, MC, Penaranda, M, Gamallo, MR, Martinez, JA, Morte-Romea, E, Del Pozo, JL, Duran-Jorda, X, Diaz-Reganon, J, Lopez-Mendoza, D, Canton, R, Oliver, A, Ruiz-Garbajosa, P, Horcajada, JP. A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?. Infectious Diseases and Therapy. 2021; 10(4)DOI:10.1007/s40121-021-00537-0. PMID:34626347. IF:6.119(Q2/3D).
01/10/2021 Macrolide resistance in Mycoplasma genitalium in Catalonia, Spain: a 1 year prospective study
Nemirosky, JL, Espelt, R, Grado, EL, Sobrino, J, Acera, A, Perez, J, Jensen, JS, Sanchez-Reus, F, Prim, N. Macrolide resistance in Mycoplasma genitalium in Catalonia, Spain: a 1 year prospective study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021; 76(10)DOI:10.1093/jac/dkab224. PMID:34278431. IF:5.758(Q1/2D).
01/08/2021 Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study
Babich, T, Naucler, P, Valik, JK, Giske, CG, Benito, N, Cardona, R, Rivera, A, Pulcini, C, Fattah, MA, Haquin, J, MacGowan, A, Grier, S, Gibbs, J, Chazan, B, Yanovskay, A, Ben Ami, R, Landes, M, Nesher, L, Zaidman-Shimshovitz, A, McCarthy, K, Paterson, DL, Tacconelli, E, Buhl, M, Mauer, S, Rodriguez-Bano, J, Morales, I, Oliver, A, de Gopegui, ER, Cano, A, Machuca, I, Gozalo-Marguello, M, Martinez, LM, Gonzalez-Barbera, EM, Alfaro, IG, Salavert, M, Beovic, B, Saje, A, Mueller-Premru, M, Pagani, L, Vitrat, V, Kofteridis, D, Zacharioudaki, M, Maraki, S, Weissman, Y, Paul, M, Dickstein, Y, Leibovici, L, Yahav, D. Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2021; 76(8)DOI:10.1093/jac/dkab134. PMID:33993273. IF:5.758(Q1/2D).
01/07/2021 Impact of the COVID-19 pandemic on tuberculosis management in Spain
Aznar, ML, Espinosa-Pereiro, J, Saborit, N, Jove, N, Martinez, FS, Perez-Recio, S, Vitoria, A, Sanjoaquin, I, Gallardo, E, Llenas-Garcia, J, Pomar, V, Garcia, IO, Cacho, J, Freitas, LGD, San Martin, JV, Rodriguez, JFG, Jimenez-Fuentes, MA, De Souza-Galvao, ML, Tortola, T, Zules, R, Molina, I, Sanchez-Montalva, A. Impact of the COVID-19 pandemic on tuberculosis management in Spain. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2021; 108DOI:10.1016/j.ijid.2021.04.075. PMID:33930543. IF:12.073(Q1/2D).
19/10/2022 C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies
Caravaca-Fontan, F, Lucientes, L, Serra, N, Cavero, T, Rodado, R, Ramos, N, Gonzalez, F, Shabaka, A, Cabello, V, Huerta, A, Pampa-Saico, S, Gutierrez, E, Quintana, LF, Lopez-Rubio, ME, Draibe, J, Titos, JA, Fernandez-Juarez, G, De Jorge, EG, Praga, M. C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022; 37(11)DOI:10.1093/ndt/gfab302. PMID:34677610. IF:6.100(Q1/2D).
24/01/2022 Multicentre study on the reproducibility of MALDI-TOF MS for nontuberculous mycobacteria identification
Rodriguez-Temporal, D, Alcaide, F, Marekovic, I, O'Connor, JA, Gorton, R, van Ingen, J, Van den Bossche, A, Hery-Arnaud, G, Beauruelle, C, Orth-Holler, D, Palacios-Gutierrez, JJ, Tudo, G, Bou, G, Ceyssens, PJ, Garrigo, M, Gonzalez-Martin, J, Greub, G, Hrabak, J, Ingebretsen, A, Mediavilla-Gradolph, MC, Oviano, M, Palop, B, Pranada, AB, Quiroga, L, Ruiz-Serrano, MJ, Rodriguez-Sanchez, B. Multicentre study on the reproducibility of MALDI-TOF MS for nontuberculous mycobacteria identification. Scientific Reports. 2022; 12(1)DOI:10.1038/s41598-022-05315-7. PMID:35075208. IF:4.600(Q2/4D).
01/01/2022 Viral Culture Confirmed SARS-CoV-2 Subgenomic RNA Value as a Good Surrogate Marker of Infectivity
Bravo, MS, Berengua, C, Marin, P, Esteban, M, Rodriguez, C, del Cuerpo, M, Miro, E, Cuesta, G, Mosquera, M, Sanchez-Palomino, S, Vila, J, Rabella, N, Marcos, MA. Viral Culture Confirmed SARS-CoV-2 Subgenomic RNA Value as a Good Surrogate Marker of Infectivity. JOURNAL OF CLINICAL MICROBIOLOGY. 2022; 60(1)DOI:10.1128/JCM.01609-21. PMID:34669457. IF:9.400(Q1/2D).
01/12/2021 Oral Antibiotic Prophylaxis Lowers Surgical Site Infection in Elective Colorectal Surgery: Results of a Pragmatic Cohort Study in Catalonia
Badia, JM, Flores-Yelamos, M, Vazquez, A, Arroyo-Garcia, N, Puig-Asensio, M, Pares, D, Pera, M, Lopez-Contreras, J, Limon, E, Pujol, M. Oral Antibiotic Prophylaxis Lowers Surgical Site Infection in Elective Colorectal Surgery: Results of a Pragmatic Cohort Study in Catalonia. Journal of Clinical Medicine. 2021; 10(23)DOI:10.3390/jcm10235636. PMID:34884337. IF:4.964(Q2/4D).
01/12/2021 How to Handle Concomitant Asymptomatic Prosthetic Joints During an Episode of Hematogenous Periprosthetic Joint Infection, a Multicenter Analysis
Wouthuyzen-Bakker, M, Sebillotte, M, Arvieux, C, Fernandez-Sampedro, M, Senneville, E, Barbero, JM, Lora-Tamayo, J, Aboltins, C, Trebse, R, Salles, MJ, Kramer, TS, Ferrari, M, Garcia-Canete, J, Benito, N, Diaz-Brito, V, Del Toro, MD, Scarborough, M, Soriano, A. How to Handle Concomitant Asymptomatic Prosthetic Joints During an Episode of Hematogenous Periprosthetic Joint Infection, a Multicenter Analysis. CLINICAL INFECTIOUS DISEASES. 2021; 73(11)DOI:10.1093/cid/ciaa1222. PMID:32813012. IF:20.999(Q1/1D).
01/12/2021 Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study
Perez-Recio, S, Pallares, N, Grijota-Camino, MD, Sanchez-Montalva, A, Barcia, L, Campos-Gutierrez, S, Pomar, V, Rabunal-Rey, R, Balcells, ME, Gazel, D, Montiel, N, Vicente, D, Goic-Barisic, I, Schon, T, Paues, J, Marekovic, I, Cacho-Calvo, J, Barac, A, Goletti, D, Garcia-Gasalla, M, Barcala, JM, Tortola, MT, Anibarro, L, Suarez-Toste, I, Moga, E, Gude-Gonzalez, MJ, Naves, R, Karsligil, T, Martin-Penaranda, T, Stevanovic, G, Trigo, M, Rubio, V, Karaoglan, I, Bayram, N, Alcaide, F, Tebe, C, Santin, M. Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study. Microbiology Spectrum. 2021; 9(3)DOI:10.1128/Spectrum.00972-21. PMID:34756079. IF:9.043(Q1/2D).
28/10/2022 Induction immunosuppression and outcome in kidney transplant recipients with early COVID-19 after transplantation
Toapanta, N, Jimenez, S, Molina-Gomez, M, Maruri-Kareaga, N, Llinas-Mallol, L, Villanego, F, Facundo, C, Rodriguez-Ferrero, M, Montero, N, Vazquez-Sanchez, T, Gutierrez-Dalmau, A, Beneyto, I, Franco, A, Hernandez-Vicente, A, Perez-Tamajon, ML, Martin, P, Ramos-Verde, AM, Castaneda, Z, Bestard, O, Moreso, F. Induction immunosuppression and outcome in kidney transplant recipients with early COVID-19 after transplantation. Clinical Kidney Journal. 2022; 15(11)DOI:10.1093/ckj/sfac112. PMID:36320365. IF:4.600(Q1/2D).
01/08/2022 Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study
Babich, T, Naucler, P, Valik, JK, Giske, CG, Benito, N, Cardona, R, Rivera, A, Pulcini, C, Fattah, MA, Haquin, J, Macgowan, A, Grier, S, Chazan, B, Yanovskay, A, Ben Ami, R, Landes, M, Nesher, L, Zaidman-Shimshovitz, A, McCarthy, K, Paterson, DL, Tacconelli, E, Buhl, M, Mauer, S, Rodriguez-Bano, J, de Cueto, M, Oliver, A, de Gopegui, ER, Cano, A, Machuca, I, Gozalo-Marguello, M, Martinez-Martinez, L, Gonzalez-Barbera, EM, Alfaro, IG, Salavert, M, Beovic, B, Saje, A, Mueller-Premru, M, Pagani, L, Vitrat, V, Kofteridis, D, Zacharioudaki, M, Maraki, S, Weissman, Y, Paul, M, Dickstein, Y, Leibovici, L, Yahav, D. Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study. Infectious Diseases and Therapy. 2022; 11(4)DOI:10.1007/s40121-022-00657-1. PMID:35612693. IF:5.400(Q2/3D).
01/06/2022 An interventional nationwide surveillance program lowers postoperative infection rates in elective colorectal surgery. A cohort study (2008-2019)
Arroyo-Garcia N., Badia J.M., Vázquez A., Pera M., Parés D., Limón E., Almendral A., Piriz M., Díez C., Fraccalvieri D., López-Contreras J., Pujol M., VINCat Program. An interventional nationwide surveillance program lowers postoperative infection rates in elective colorectal surgery. A cohort study (2008-2019). International Journal of Surgery. 2022; 102DOI:10.1016/j.ijsu.2022.106611. PMID:35427799. IF:15.300(Q1/1D).
12/05/2022 Trends in the epidemiology of catheter-related bloodstream infections; towards a paradigm shift, Spain, 2007 to 2019
Badia-Cebada, L, Penafiel, J, Saliba, P, Andres, M, Camara, J, Domenech, D, Jimenez-Martinez, E, Marron, A, Moreno, E, Pomar, V, Vaque, M, Limon, E, Masats, U, Pujol, M, Gasch, O. Trends in the epidemiology of catheter-related bloodstream infections; towards a paradigm shift, Spain, 2007 to 2019. Eurosurveillance. 2022; 27(19)DOI:10.2807/1560-7917.ES.2022.27.19.2100610. PMID:35551704. IF:19.000(Q1/1D).
01/05/2022 Activity of Antibiotics and Potential Antibiofilm Agents against Biofilm-Producing Mycobacterium avium-intracellulare Complex Causing Chronic Pulmonary Infections
Portell-Buj E., González-Criollo C., López-Gavín A., Fernández-Pittol M., Busquets M.A., Estelrich J., Garrigó M., Rubio M., Tudó G., Gonzalez-Martin J.. Activity of Antibiotics and Potential Antibiofilm Agents against Biofilm-Producing Mycobacterium avium-intracellulare Complex Causing Chronic Pulmonary Infections. Antibiotics-Basel. 2022; 11(5)DOI:10.3390/antibiotics11050589. PMID:35625233. IF:4.800(Q1/3D).
20/04/2022 Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection
Abras, A, Ballart, C, Fernandez-Arevalo, A, Pinazo, MJ, Gascon, J, Munoz, C, Gallego, M. Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection. CLINICAL MICROBIOLOGY REVIEWS. 2022; 35(2)DOI:10.1128/cmr.00152-21. PMID:35239422. IF:36.800(Q1/1D).
01/04/2022 A New Variant of the aadE-sat4-aphA-3 Gene Cluster Found in a Conjugative Plasmid from a MDR Campylobacter jejuni Isolate
Guirado, P, Miro, E, Iglesias-Torrens, Y, Navarro, F, Campoy, S, Alioto, TS, Gomez-Garrido, J, Madrid, C, Balsalobre, C. A New Variant of the aadE-sat4-aphA-3 Gene Cluster Found in a Conjugative Plasmid from a MDR Campylobacter jejuni Isolate. Antibiotics-Basel. 2022; 11(4)DOI:10.3390/antibiotics11040466. PMID:35453217. IF:4.800(Q1/3D).
01/03/2022 Epidemiology of Echovirus 30 Infections Detected in a University Hospital in Catalonia, Spain, in 1995-2020
del Cuerpo, M, de Audicana, JG, Fernandez-Garcia, MD, Marin, P, Esteban, M, Espanol, M, Cabrerizo, M, Rabella, N. Epidemiology of Echovirus 30 Infections Detected in a University Hospital in Catalonia, Spain, in 1995-2020. Microorganisms. 2022; 10(3)DOI:10.3390/microorganisms10030592. PMID:35336167. IF:4.500(Q2/4D).
01/01/2022 Recomendaciones del Comité Español del Antibiograma (COESANT) para la realización de los Informes de Sensibilidad Antibiótica Acumulada
Larrosa M.N., Canut-Blasco A., Benito N., Cantón R., Cercenado E., Docobo-Pérez F., Fernández-Cuenca F., Fernández-Domínguez J., Guinea J., López-Navas A., Moreno M.Á., Morosini M.I., Navarro F., Martínez-Martínez L., Oliver A.. Recomendaciones del Comité Español del Antibiograma (COESANT) para la realización de los Informes de Sensibilidad Antibiótica Acumulada. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2022; DOI:10.1016/j.eimc.2022.01.004. PMID:36175285. IF:2.500(Q4/8D).
18/12/2023 Evaluation of the Diagnostic Sensitivity of the VIASURE Leishmania Real-Time PCR Detection Kit Prototype for the Diagnosis of Cutaneous and Visceral Leishmaniasis
Arnau, A, Abras, A, Ballart, C, Fernández-Arévalo, A, Torrico, MC, Tebar, S, Llovet, T, Gállego, M, Muñoz, C. Evaluation of the Diagnostic Sensitivity of the VIASURE Leishmania Real-Time PCR Detection Kit Prototype for the Diagnosis of Cutaneous and Visceral Leishmaniasis. Transboundary and Emerging Diseases. 2023; 2023DOI:10.1155/2023/1172087. PMID:. IF:3.500(Q1/1D).
01/10/2023 Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions.
de Mendoza C, Rando A, Miró E, Pena MJ, Rodríguez-Avial I, Ortega D, González-Praetorius A, Reina G, Pintos I, Pozuelo MJ, Soriano V. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions.. JOURNAL OF CLINICAL VIROLOGY. 2023; 167DOI:10.1016/j.jcv.2023.105578. PMID:37660433. IF:4.000(Q2/4D).
01/08/2023 Outcomes of octogenarians and nonactogenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study
Atamna, A, Margalit, I, Ayada, G, Babich, T, Naucler, P, Valik, JK, Giske, CG, Benito, N, Cardona, R, Rivera, A, Pulcini, C, Fattah, MA, Haquin, J, Macgowan, A, Chazan, B, Yanovskay, A, Ben Ami, R, Landes, M, Nesher, L, Zaidman-Shimshovitz, A, McCarthy, K, Paterson, DL, Tacconelli, E, Buhl, M, Mauer, S, Rodriguez-Bano, J, de Cueto, M, Oliver, A, de Gopegui, ER, Cano, A, Machuca, I, Gozalo-Marguello, M, Martinez-Martinez, L, Gonzalez-Barbera, EM, Alfaro, IG, Salavert, M, Beovic, B, Saje, A, Mueller-Premru, M, Pagani, L, Vitrat, V, Kofteridis, D, Zacharioudaki, M, Maraki, S, Weissman, Y, Paul, M, Dickstei, Y, Yahav, D. Outcomes of octogenarians and nonactogenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study. INFECTION. 2023; 51(4)DOI:10.1007/s15010-022-01973-x. PMID:36571672. IF:5.400(Q1/2D).
01/07/2023 Late poor outcomes of Clostridioides difficile infections in oncological patients: A multicentre cohort study
Calbo, E, Hernandez, S, Sopena, N, Castella, L, Lopez-Contreras, J, Cuquet, J, Lopez-Sanchez, M, Perez, R, Gudiol, C, Coloma, A, Marimon, M, Espinach, J, Andres, M, Martos, P, Rodrigues, GC, Limon, E. Late poor outcomes of Clostridioides difficile infections in oncological patients: A multicentre cohort study. Journal Of Infection Prevention. 2023; 24(4)DOI:10.1177/17571774231165410. PMID:37333870. IF:(Q/D).
01/07/2023 Management of immunosuppressive therapy in kidney transplant recipients with COVID-19. A multicentre national study derived from the Spanish Society of Nephrology COVID registry
López-Oliva M.O., Pérez-Flores I., Molina M., José Aladrén M., Trujillo H., Redondo-Pachón D., López V., Facundo C., Villanego F., Rodríguez M., Carmen Ruiz M., Antón P., Rivas-Oural A., Cabello S., Portolés J., de la Vara L., Tabernero G., Valero R., Galeano C., Moral E., Ventura A., Coca A., Ángel Muñoz M., Hernández-Gallego R., Shabaka A., Ledesma G., Bouarich H., Ángeles Rodríguez M., Pérez Tamajón L., Cruzado L., Emilio Sánchez J., Jiménez C.. Management of immunosuppressive therapy in kidney transplant recipients with COVID-19. A multicentre national study derived from the Spanish Society of Nephrology COVID registry. Nefrologia. 2023; 43(4)DOI:10.1016/j.nefroe.2023.08.004. PMID:37661514. IF:(Q/D).
22/06/2023 Impact of Intermediate Susceptibility to Penicillin on Antimicrobial Treatment and Outcomes of Endocarditis Caused by Viridans and Gallolyticus Group Streptococci
Escrihuela-Vidal, F, Berbel, D, Fernández-Hidalgo, N, Escola-Vergé, L, Muñoz, P, Olmedo, M, Goenaga, MA, Goikoetxea, J, Fariñas, MC, De Alarcón, A, Miró, JM, Ojeda, G, Plata, A, Cuervo, G, Carratalà, J. Impact of Intermediate Susceptibility to Penicillin on Antimicrobial Treatment and Outcomes of Endocarditis Caused by Viridans and Gallolyticus Group Streptococci. CLINICAL INFECTIOUS DISEASES. 2023; 77(9)DOI:10.1093/cid/ciad375. PMID:37345869. IF:8.200(Q1/1D).
10/05/2023 Epidemiology and antimicrobial resistance profile of Neisseria gonorrhoeae in Catalonia, Spain, 2016-2019
Herrero, M, Broner, S, Cruells, A, Esteve, S, Ferre, L, Mendioroz, J, Jane, M, Pitart, C. Epidemiology and antimicrobial resistance profile of Neisseria gonorrhoeae in Catalonia, Spain, 2016-2019. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2023; 42(7)DOI:10.1007/s10096-023-04601-0. PMID:37162616. IF:3.700(Q2/3D).
01/05/2023 Susceptibility to hepatitis B virus infection in adults living in Spain
Soriano, V, Aguilera, A, Benito, R, Gonzalez-Diez, R, Miro, E, Liendo, P, Rodriguez-Diaz, JC, Cabezas, T, Richart, A, Ramos, JM, Barea, L, Alvarez, C, Trevino, A, Gomez-Gallego, F, Corral, O, de Mendoza, C. Susceptibility to hepatitis B virus infection in adults living in Spain. LIVER INTERNATIONAL. 2023; 43(5)DOI:10.1111/liv.15548. PMID:36809581. IF:6.000(Q1/2D).
01/05/2023 Randomized Clinical Trial of the Need for Antibiotic Treatment for Low-Risk Catheter-Related Bloodstream Infection Caused by Coagulase-Negative Staphylococci
Badia-Cebada, L, Carmezim, J, Perez-Rodriguez, MT, Bereciartua, E, Lopez, LE, Montenegro, MR, Pomar, V, Andres, M, Petkova, E, Sopena, N, Lora-Tamayo, J, Monsalvez, V, Ramirez-Hidalgo, MF, Gomez-Zorrilla, S, Boix, L, Meije, Y, Jimenez, E, Gasch, O. Randomized Clinical Trial of the Need for Antibiotic Treatment for Low-Risk Catheter-Related Bloodstream Infection Caused by Coagulase-Negative Staphylococci. Antibiotics-Basel. 2023; 12(5)DOI:10.3390/antibiotics12050839. PMID:37237744. IF:4.300(Q1/2D).
01/04/2023 Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohort
Escrihuela-Vidal F., Kaasch A.J., Von Cube M., Rieg S., Kern W.V., Seifert H., Song K.-H., Liao C.-H., Tilley R., Gott H., Scarborough M., Gordon C., Llewelyn M.J., Kuehl R., Morata L., Soriano A., Edgeworth J., De Gopegui E.R., Nsutebu E., Cisneros J.M., Fowler V.G., Thwaites G., López-Contreras J., Barlow G., Ternavasio-De La Vega H.G., Rodríguez-Baño J., López-Cortés L.E., Endocarditis And Sepsis. Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohort. CLINICAL MICROBIOLOGY AND INFECTION. 2023; 29(4)DOI:10.1016/j.cmi.2022.10.019. PMID:36283610. IF:10.900(Q1/1D).
12/01/2023 Guideline for management of septic arthritis in native joints (SANJO)
Ravn C., Neyt J., Benito N., Abreu M.A., Achermann Y., Bozhkova S., Coorevits L., Ferrari M.C., Gammelsrud K.W., Gerlach U.-J., Giannitsioti E., Gottliebsen M., Jørgensen N.P., Madjarevic T., Marais L., Menon A., Moojen D.J., Pääkkönen M., Pokorn M., Pérez-Prieto D., Renz N., Saavedra-Lozano J., Sabater-Martos M., Sendi P., Tevell S., Vogely C., Soriano A.. Guideline for management of septic arthritis in native joints (SANJO). Journal Of Bone And Joint Infection. 2023; 8(1)DOI:10.5194/jbji-8-29-2023. PMID:36756304. IF:(Q/D).
11/01/2023 Sodium-glucose cotransporter-2 inhibitor therapy in kidney transplant patients with type 2 or post-transplant diabetes: an observational multicentre study
Fructuoso, AIS, Raba, AB, Deras, EB, Sanchez, LAV, San Cecilio, RV, Esteve, AF, Vega, LC, Martinez, E, Garcia, MEG, Coronado, PS, Morales, NDV, Larrondo, SZ, Cano, NR, Blanca, AM, Marrero, DH, Castello, IB, Ramos, JP, Ochoa, AS, Molas, CF, Roncero, FG, Ramirez, AT, Guldris, SC, Flores, IP. Sodium-glucose cotransporter-2 inhibitor therapy in kidney transplant patients with type 2 or post-transplant diabetes: an observational multicentre study. Clinical Kidney Journal. 2023; 16(6)DOI:10.1093/ckj/sfad007. PMID:37260993. IF:3.900(Q1/2D).